weight loss medication not glp-1 Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care Anti-obesity drugs are closing the

European Radiology , 17(1), 211-219

He J, Lu Y, Song X, Gong X, Li Y

This form is often used in medical and cosmetic treatments but requires professional administration

Although its beneficial for weight loss, only one in eight Americans was currently on a GLP-1 agonist in 2025

MOTS-c: A mitochondrial-derived peptide that helps with energy production, metabolic health, and cellular resilience

ROS acts as a central hub connecting ferroptosis to PCa pathogenesis, amplified by inflammatory signals and redox-sensitive transcription factors (e.g., Nrf2, HIF-1) that either directly enhance oxidative stress or indirectly modulate ferroptosis susceptibility [Figure 2A]